Skip to content

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism

Screening of Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04477564
Acronym
CHIPS
Enrollment
150
Registered
2020-07-20
Start date
2020-07-03
Completion date
2023-06-13
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Keywords

Clonal Hematopoiesis of indeterminate potential

Brief summary

The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism. The study investigators make the assumption that these patients present mutations involved in CHIP occurrence.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism * Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107))

Exclusion criteria

* Patients less than 50 years old * Patient who has refused that their DNA was kept and used in the context of research on venous thromboembolism

Design outcomes

Primary

MeasureTime frameDescription
DNMT3A mutations screeningFor sequencing analysis: 2 monthsNext generation sequencing

Secondary

MeasureTime frameDescription
TET2, ASXL1, TP53, JAK2, SF3B1, SRSF2, GNB1, CBL, BCOR, SH2B3, PPM1D mutations screeningFor sequencing analysis: 2 monthsNext generation sequencing

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026